Access my individual Investor account information, including account balances, transaction history and tax forms.
Access AccountBy clicking "Proceed", you will be directed to a server of an unaffiliated company who is a service provider of Voya Investment Management. By clicking the button, you will leave this site and proceed to the selected site. Voya Investment Management, its subsidiaries or affiliates, do not guarantee the accuracy or timeliness of the information contained on the website.
ProceedSign up for the convenience of paperless communications
Go NowYou will be notified by e-mail when these communications become available on the Internet. Printed copies of these communications may still be requested. Documents that are not available on the Internet will continue to be sent to you by mail.
If you have any questions about our e-Delivery program, please call (800) 992-0180.
For access to advisor-only content, including the exclusive Retirement University blog, learning modules and tools
Log In
With two COVID-19 vaccines approved in the U.S. and more fiscal stimulus about to be deployed...
Despite the recent coronavirus surge and probable upcoming socially isolating, winter hunkering required, we think stocks can continue to hold their own against bonds.
While the world has cheered news of a vaccine on the horizon, it will not be available in time to help fight the recent surge in new cases of the virus.
Highlights from the week of January 8 – January 14, 2021.
A detailed analysis of the senior loan asset class and outlook for 2021.
With two COVID-19 vaccines approved in the U.S. and more fiscal stimulus about to be deployed, there is a clear bridge (vaccine) to post-COVID normalcy and abutments (stimulus) that should keep the recovery on course.
Highlights from the week of January 1 – January 7, 2021.
Highlights from the week of December 11 – December 17, 2020.
Highlights from the week of December 4 – December 10, 2020.
Despite the recent coronavirus surge and probable upcoming socially isolating, winter hunkering required, we think stocks can continue to hold their own against bonds.
U.S. stocks advanced during a holiday-shortened week, with strong gains in the Dow, Nasdaq Composite and S&P 500. Growing optimism about deploying a Covid vaccine sooner than expected boosted stocks and trimmed market volatility.
While the world has cheered news of a vaccine on the horizon, it will not be available in time to help fight the recent surge in new cases of the virus.
We continue to believe that risk-assets are worth the discomfort of uncertainty.